Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Dillon

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Epidemiology|September 6, 2021
Systematic review of diabetic eye disease practice guidelines: more applicability, transparency and development rigor are neededRajendra Gyawali, Melinda Toomey, Fiona Stapleton, et al.
Plos One|March 17, 2022
Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020TeeKeat Teoh, James Powell, Jillian O'Keeffe, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|February 15, 2017
PrevenTing Falls in a high-risk, vision-impaired population through specialist ORientation and Mobility services: protocol for the PlaTFORM randomised trialLisa Keay, Lisa Dillon, Lindy Clemson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2003
Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesisMichael Mourez, Ming Yan, D Borden Lacy, et al.
Bioorganic & Medicinal Chemistry|June 15, 2007
Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductaseLarry D Bratton, Bruce Auerbach, Chulho Choi, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitorsJeffrey A Pfefferkorn, Chulho Choi, Yuntao Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-designScott D Larsen, Toni-Jo Poel, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|December 13, 2007
Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemiaJeffrey A Pfefferkorn, Chulho Choi, Scott D Larsen, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2007
Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitorsWilliam K C Park, Robert M Kennedy, Scott D Larsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitorsJeffrey A Pfefferkorn, Yuntao Song, Kuai-Lin Sun, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Epidemiology|September 6, 2021
Systematic review of diabetic eye disease practice guidelines: more applicability, transparency and development rigor are neededRajendra Gyawali, Melinda Toomey, Fiona Stapleton, et al.
Plos One|March 17, 2022
Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020TeeKeat Teoh, James Powell, Jillian O'Keeffe, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|February 15, 2017
PrevenTing Falls in a high-risk, vision-impaired population through specialist ORientation and Mobility services: protocol for the PlaTFORM randomised trialLisa Keay, Lisa Dillon, Lindy Clemson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2003
Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesisMichael Mourez, Ming Yan, D Borden Lacy, et al.
Bioorganic & Medicinal Chemistry|June 15, 2007
Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductaseLarry D Bratton, Bruce Auerbach, Chulho Choi, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitorsJeffrey A Pfefferkorn, Chulho Choi, Yuntao Song, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-designScott D Larsen, Toni-Jo Poel, Kevin J Filipski, et al.
Journal of Medicinal Chemistry|December 13, 2007
Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemiaJeffrey A Pfefferkorn, Chulho Choi, Scott D Larsen, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2007
Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitorsWilliam K C Park, Robert M Kennedy, Scott D Larsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitorsJeffrey A Pfefferkorn, Yuntao Song, Kuai-Lin Sun, et al.
Pageof 4